Article ID Journal Published Year Pages File Type
2140816 Lung Cancer 2013 7 Pages PDF
Abstract
In this cohort of patients treated for stage IV NSCLC, renal function falls below commonly used thresholds for cisplatin and for pemetrexed in fewer than a quarter of patients. However, these declines may preclude administration of these drugs for prolonged periods.
Keywords
Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Cancer Research
Preview
Impact of renal function on treatment options and outcomes in advanced non-small cell lung cancer
Authors
, , ,